Search

Author/Creator Fahs, Assil

1. 483 Improvement in Behavioral, Cellular and Molecular Outcomes with Connexin Inhibitors Administration in a Porcine Spinal Cord Injury Model. (1st April 2022)

Authors:
Alok, Khaled; Moussalem, Charbel; Minassian, Georges; Baassiri, Wassim; Kobeissy, Firas; Jurjus, Abdo; Hamade, Eva; Ayoub, Abeer J.; Habib, Aida; Fahs, Assil; El Houshiemy, Mohamad N.; Bsat, Shadi; Alomari, Safwan; Omeis, Ibrahim
Journal:
Neurosurgery
Issue:
Volume 68(2022)Supplement 1
Page Start:
119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma. Issue 3 (4th March 2019)

Authors:
Ghayad, Sandra E.; Rammal, Ghina; Sarkis, Omar; Basma, Hussein; Ghamloush, Farah; Fahs, Assil; Karam, Mia; Harajli, Mohamad; Rabeh, Wissam; Mouawad, Joe E.; Zalzali, Hassan; Saab, Raya
Journal:
Cancer biology & therapy
Issue:
Volume 20:Issue 3(2019)
Page Start:
272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗